elafibranor
Sign in to saveElafibranor, sold under the brand name Iqirvo, is a medication used for the treatment of primary biliary cholangitis.
Wikidata facts
- Mass
- 384.14
Show 3 more facts
- chemical formula
- C₂₂H₂₄O₄S
- canonical SMILES
- CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)C=CC(=O)C2=CC=C(C=C2)SC
- isomeric SMILES
- CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)/C=C/C(=O)C2=CC=C(C=C2)SC
via Wikidata · CC0
~3 min read
Article
8 sectionsContents
- Medical uses
- Adverse effects
- History
- Society and culture
- Legal status
- Names
- Research
- References
Elafibranor, sold under the brand name Iqirvo, is a medication used for the treatment of primary biliary cholangitis.
Elafibranor is a dual PPARα/δ agonist. Elafibranor and its main active metabolite GFT1007 are peroxisome proliferator-activated receptor (PPAR) agonists, both of which activate PPAR-alpha, PPAR-gamma, and PPAR-delta in vitro.
Connections
liver
Entity
medication
Entity
digital object identifier
Entity
chemical formula
Entity
bile
Entity
ibuprofen
Entity
molar mass
Entity
Q180686
Entity
phospholipids
Entity
DL-methionine
Entity
CAS Registry Number
Entity
type 2 diabetes
Disease
Q229883
Entity
PubChem
Entity
United States Food and Drug Administration
Entity
Anatomical Therapeutic Chemical Classification System
Entity
cannabidiol
Entity
MedlinePlus
Entity
arachidonic acid
Entity
simplified molecular input line entry specification
Entity